Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $18.2 million.

  • Cross Country Healthcare's Depreciation & Amortization (CF) fell 911.52% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year decrease of 560.83%. This contributed to the annual value of $18.2 million for FY2024, which is 80.12% down from last year.
  • Cross Country Healthcare's Depreciation & Amortization (CF) amounted to $18.2 million in FY2024, which was down 80.12% from $18.3 million recorded in FY2023.
  • In the past 5 years, Cross Country Healthcare's Depreciation & Amortization (CF) registered a high of $18.3 million during FY2023, and its lowest value of $9.9 million during FY2021.
  • For the 5-year period, Cross Country Healthcare's Depreciation & Amortization (CF) averaged around $14.3 million, with its median value being $12.7 million (2020).
  • Per our database at Business Quant, Cross Country Healthcare's Depreciation & Amortization (CF) plummeted by 2224.77% in 2021 and then surged by 4588.9% in 2023.
  • Annual analysis of 5 years shows Cross Country Healthcare's Depreciation & Amortization (CF) stood at $12.7 million in 2020, then dropped by 22.25% to $9.9 million in 2021, then grew by 27.65% to $12.6 million in 2022, then surged by 45.89% to $18.3 million in 2023, then decreased by 0.8% to $18.2 million in 2024.
  • Its last three reported values are $18.2 million in FY2024, $18.3 million for FY2023, and $12.6 million during FY2022.